Recall Register

Drug recall: Atovaquone Oral Suspension, USP, 750 mg/5 mL, 210 mL bottle, Rx Only, Mfd. By: KVK-Tech, Inc., Newtown, PA 18940, NDC…

Class I FDA enforcement event 88220. Recall start date: . Status in the FDA record: Terminated. Termination date: .

Reason for recall, in the words of FDA

Temperature abuse: the firm received customer complaints of unusual grittiness in the product.

Class I, in the words of FDA

a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death

KVK-Tech, Inc. started this drug recall on 2 Jul 2021. The firm address in the FDA record is in Newtown, PA. FDA put the recall in Class I. FDA event 88220 has 1 product record. The first FDA enforcement report date is 1 Sep 2021. The record gives the status Terminated, with the termination date 23 May 2022.

It is important to note that most of the time recall classifications are determined after the recalling firm provides all of the information needed to determine the risk posed to public health. The classification and posting in the FDA Enforcement Report should not be seen as an expansion or change to a firm’s voluntary public warning.

FDA publishes these words. Source: FDA, Enforcement Reports, Important Note, read on . openFDA export of .

Distribution

In the words of FDA.

Product was distributed to one distributor who may have further distributed Nationwide in the USA.

Recalling firm

KVK-Tech, Inc., Newtown, PA.

Recalling firm: The firm that the FDA record names for a recall.

FDA records how the recall started: Voluntary: Firm initiated.

Products

1 product record in the event.

FDA event 88220: product records
Recall numberProductQuantityClassStatusReport date
D-0772-2021Atovaquone Oral Suspension, USP, 750 mg/5 mL, 210 mL bottle, Rx Only, Mfd. By: KVK-Tech, Inc., Newtown, PA 18940, NDC 10702-223-21.1,692 bottlesClass ITerminated1 Sep 2021

openFDA, about the status: FDA does not update the status of a recall after the recall has been classified according to its level of hazard. As such, the status of a recall (open, completed, or terminated) will remain unchanged after published in the Enforcement Reports. Source: openFDA, Drug Recall Enforcement Reports, Disclaimer.

Enforcement report: The FDA publication that lists recalls. It has one record for each product of a recall.

Enforcement event: All the product records that have one FDA event number. This site shows one event on one page.

Class I: The highest of the three FDA recall classes.

The event in context

Drug events that started in 2021
299
Share of these events in Class I
19%
Product records in this event
1Median of the firm: 1
Events of the firm on the register
12

Other events of the firm

Other FDA enforcement events of KVK-Tech, Inc.
InitiatedProduct (first record)TypeClassRecords
9 May 2025Indomethacin Extended-Release Capsules USP, 75 mg, 100-count bottle, Rx only, Mfd. By: KVK-Tech, Inc., Newtown, PA, 1894DrugClass II2
20 Sep 2023Betaxolol Tablets, USP 10 mg, Rx Only, 100 count bottles, Mfd by: KVK Tech Inc., Newtown, PA 18940, Made in USA, NDC# 10DrugClass I1
27 Apr 2021Hydrocodone Bitartrate and Homatropine Methlybromide tablets, USP, 5 mg/ 1.5 mg, 30-count bottle, Rx only, Mfd. By:KVK-TDrugClass III1
18 Dec 2020Benzhydrocodone and Acetaminophen Tablets, CII, 6.12mg/ 325mg, 100 Tablets, Rx Only, Manufactured for: KVK-Tech, Inc., NDrugClass III1
1 Nov 2019Hydrocodone Bitartrate and Homatropine Methlybromide Oral Solution 5 mg/1.5 mg per 5 mL, 473 mL bottles, Rx only, Mfd. bDrugClass II1
4 Oct 2019Methylphenidate Hydrochloride Oral Solution 5mg per 5mL, 500 mL Bottle, Sugar Free Alcohol Free, Rx Only, Mfd by: KVK TeDrugClass III1
11 Dec 2018Oxybutynin Chloride Tablets, USP, 5 mg, 500-count bottle, Rx only, Mfd. By: KVK-Tech, Inc., Newtown, PA 18940, NDC 10702DrugClass II1
3 Aug 2017Phentermine HCL Capsules, USP 15 mg, packaged in a) 100-count bottles (NDC 10702-026-01), and b) 1000-count bottles (NDCDrugClass III1
5 May 2016Benzphetamine Hydrochloride Tablets, 50 mg, 30-count bottle, RX only, Mfd by: KVK-TECH, INC., Newtown, PA 18940, NDC 107DrugClass III1
14 Jul 2015Phentermine Hydrochloride Capsules, USP, 15 mg, packaged in a) 100-count bottle (NDC 10702-0026-01; UPC 3 10702 02601 8)DrugClass III1

KVK-Tech, Inc.: all 12 events

Official channels

Cite this page

Recall Register. FDA enforcement event 88220. https://recallregister.com/fda/i/88220/. Source: openFDA enforcement reports. Data through .

Sources

Source
openFDA drug enforcement reports
Licence
CC0 1.0
Export date
28 Sep 2026
Newest FDA report date on the register
23 Sep 2026

FDA has one record for each product. This site puts the records with the same event number on one page. The class of the event is the highest class of its records. How the register is made. Report an error.

Questions

Where was the product distributed?
The FDA record gives this distribution: Product was distributed to one distributor who may have further distributed Nationwide in the USA.
What quantity of product is in FDA event 88220?
The FDA record gives this quantity: 1,692 bottles
How did the recall start?
The FDA record says: Voluntary: Firm initiated
How many drug recalls of 2021 have the same class?
19% of the 299 drug events that started in 2021 are in Class I.